Meta-analysis of the efficacy and safety of Finerenone in diabetic kidney disease
Abstract
Objective: This study is aimed to systematically evaluate the efficacy and safety of Finerenone (BAY 94-8862) in the treatment of diabetic kidney disease.
Method: Databases including PubMed, Embase, and Web of science were searched for randomized controlled trials that assessed Finerenone in patients with diabetic kidney disease and were published up to January 7, 2025. The quality evaluation of literatures and meta-analysis were performed using RevMan 5.4 software and independently operated by 2 experimenters.
Results: Seven randomized controlled trials involving 33,455 patients were included. The efficacy outcomes were the ratio of urine albumin creatine ratio at posttreatment versus at baseline (mean difference: -0.30; 95% confidence interval [CI; -0.32, -0.27]; P < .00001; I2 = 0%), the primary composite outcome (hazard ratio [HR]: 0.81; 95% CI [0.76, 0.87]; P < .00001; I2 = 13%), the secondary composite outcome (HR: 0.82; 95% CI [0.74, 0.91]; P = .0001; I2 = 0%), kidney failure (HR: 0.76; 95% CI [0.70, 0.83]; P < .00001; I2 = 0%), and the risk of end stage kidney disease (HR: 0.87; 95% CI [0.77, 0.99]; P = .03; I2 = 46%). The safety outcome was the incidence of adverse events (risk ratio: 1.00; 95% CI [0.99, 1.00]; P = .38; I2 = 0%) and the number of patients suffering from hyperkalemia (risk ratio: 2.19; 95% CI [2.04, 2.34]; P < .00001; I2 = 0%).
Conclusion: Results of meta-analysis showed that Finerenone could significantly reduce urine albumin creatine ratio levels.…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 33,455 participants or records.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.